Documento de consenso sobre la prevención y el tratamiento de la tuberculosis en pacientes candidatos a tratamiento biológico-Reference-Cited by-同舟云学术

Documento de consenso sobre la prevención y el tratamiento de la tuberculosis en pacientes candidatos a tratamiento biológico

Published:2016-01 Issue:1 Volume:52 Page:36-45
ISSN:0300-2896
Container-title:Archivos de Bronconeumología
language:es
Short-container-title:Archivos de Bronconeumología

Author:

Mir Viladrich Isabel,Daudén Tello Esteban,Solano-López Guillermo,López Longo Francisco Javier,Taxonera Samso Carlos,Sánchez Martínez Paquita,Martínez Lacasa Xavier,García Gasalla Mercedes,Dorca Sargatal Jordi,Arias-Guillén Miguel,García García José Maria

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference121 articles.

1. Infliximab approval process in Crohn's disease. Department of Health and Human Services. Public Health Service. Food and Drug Administration August 24, 1998.

2. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009;Furst;Ann Rheum Dis,2010

3. Tuberculosis associated with infliximab, a tumor necrosis factor-alpha neutralizing agent;Keane;N Engl J Med,2001

4. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report;Gomez-Reino;Arthritis Rheum,2003

5. Consensus guideline on tuberculosis and treatment of inflammatory bowel disease with infliximab. Spanish Working Group on Crohn Disease and Ulcerative Colitis;Obrador;Gastroenterol Hepatol,2003

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert views on screening for tuberculosis infection in patients commencing treatment with a biologic agent;J BRAS PNEUMOL;2024

2. Latent Tuberculosis Infection Treatment: Compliance and Factors Related with Initiation;Archivos de Bronconeumología;2023-05

3. Comentario a: Recomendaciones SER sobre prevención de infección en enfermedades reumáticas autoinmunes sistémicas;Reumatología Clínica;2023-03

4. Comments: Recommendations for prevention of infection in systemic autoimmunerheumatic diseases;Reumatología Clínica (English Edition);2023-03

5. Positive rates of interferon-γ release assay and tuberculin skin test in detection of latent tuberculosis infection: A systematic review and meta-analysis of 200,000 head-to-head comparative tests;Clinical Immunology;2022-12